HL GENOMICS Co., Ltd. (KOSDAQ:0156T0)
South Korea · Delayed Price · Currency is KRW 9,380.00
+280.00 (3.08%)
At close: Jul 31, 2026
HL GENOMICS Market Cap
HL GENOMICS has a market cap or net worth of 73 billion as of July 31, 2026.
Market Cap
73.00B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,380.00
ChartMarket Cap Chart
Since July 24, 2026, HL GENOMICS's market cap has decreased from 115.10B to 73.00B, a decrease of -36.58%. That is a compound annual growth rate of -100.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 70.82B | -2.99% |
| Jul 31, 2026 | 73.00B | 3.08% |
| Jul 30, 2026 | 70.82B | -11.65% |
| Jul 29, 2026 | 80.16B | -4.98% |
| Jul 28, 2026 | 84.36B | -19.58% |
| Jul 27, 2026 | 104.90B | -8.86% |
| Jul 24, 2026 | 115.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 87.82B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 85.27B |
| Daehan Nupharm | 78.60B |
| KOREA PHARMA | 76.67B |
| Sam-A Pharm. | 74.52B |
| Hwail Pharmaceutical | 73.57B |
| Optipharm.CO.,LTD | 67.70B |
| GL Pharm Tech | 63.12B |